Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)

Willem Johan van den Brink, Semra Palic, Isabelle Kohler, Elizabeth Cunera Maria de Lange*

*Corresponding author for this work

Research output: Contribution to JournalComment / Letter to the editorAcademic

Abstract

The third author’s name was mistakenly published with an umlaut (Isabelle Köhler). The correct spelling is “Isabelle Kohler”.

Original languageEnglish
Article number102
JournalPharmaceutical research
Volume35
Issue number5
DOIs
Publication statusPublished - 1 May 2018
Externally publishedYes

Fingerprint Dive into the research topics of 'Correction to: Access to the CNS: Biomarker Strategies for Dopaminergic Treatments (Pharmaceutical Research, (2018), 35, 3, (64), 10.1007/s11095-017-2333-x)'. Together they form a unique fingerprint.

  • Cite this